HEALTHSTORY 510· JULY 27, 2026

Drug spending is up. PhRMA wants journalists to frame it differently.

Prescription drug spending is rising, and the pharmaceutical industry's main lobbying organization is running a campaign to change how reporters describe it. Lobbying, at its most basic, means paid outreach

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 509Nvidia debt-insurance costs hit a record as $750 billion AI financing talks spook bond markets NEXT STORY 511 →More than 2,000 proposals aim to govern AI. Not one plans for the long run.

Keep reading

More from the desk.

11HEALTH

A drug for Angelman syndrome failed its final trial. Researchers say the science is not done.

A late-stage trial for an experimental Angelman syndrome drug came back negative this week, dealing a major blow to patients and to the company behind it. Late-stage, in clinical testing, means the final ro

health2 MIN

16HEALTH

Novartis heart drug pelacarsen fails its largest clinical trial

A closely watched drug for a common heart disease risk factor has failed in its biggest test. Pelacarsen, developed by Novartis, targets Lp(a), a particle made from lipids and proteins whose elevated concentrations in the blood raise the…

health1 MIN

20HEALTH

Boston cancer patients face a choice as Mass General Brigham plan drops Dana-Farber

A network split is forcing some cancer patients in Boston to choose between their doctor and their insurance coverage. A network, in plain terms, is the list of hospitals and specialists an insurer has agreed to pay for directly. Starting…

health1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk